Welcome to the Department of Urology

Mission Overview

About us

The Department of Urology is committed to excellence and improving everything we do. From our innovative patient care, to our highest caliber education program, and cutting-edge research, we work together to turn discoveries into reality and improve the lives of our patients.  


Follow us on Twitter!

The Department of Urology and our Urology Residency Program are now on Twitter!




Departmental News & Highlights

New Publications

New Faculty

We are excited to welcome new Urology faculty Dr. Vanessa Gulla! Dr. Gulla is a board certified Urologist specializing in adult urology of both men and women. She enjoys managing both the medical and surgical treatment of diverse urologic conditions. After completing her residency at Dartmouth, Dr. Gulla participated in an endourology fellowship with the NHS in Bristol, England, and has since returned to her native Northern California to practice urology at Stanford Health Care's ValleyCare in Pleasanton.

Faculty Activities

Dr. Benjamin Chung and Dr. Jay Shah were invited faculty in Delhi, India at the 2017 Max Super Specialty Hospital Video Workshop and Conference on Urologic Oncology. Faculty and trainees from Delhi and surrounding areas convened to learn from Drs. Chung and Shah on the latest techniques for management of prostate, kidney and bladder cancer.


This Department of Urology is seeking qualified faculty for several open positions to join its distinguished group of medical professionals. 

News & Events

Introducing our PGY1 all-stars!

Sean Berquist

Jessie Ge

Yash Khandwala

New ABU diplomates

Congratulations to our 7 new American Board of Urology diplomates: Drs. Winifred Adams, Judith Hagedorn, Alan Thong, Simon Conti, Janet Joy Lee, Philip Barbosa, and Mark Hsu.  

Research Highlights: Active Surveillance

In 2 recent studies published online, Dr. James Brooks and colleagues have analyzed methods to predict which men can safely be followed with active surveillance of low risk prostate cancer.  In the first study, they found that the finding on no cancer on follow-up biopsies obtained on men while they were on surveillance predicted a much lower risk that they would need treatment (surgery or radiation therapy) 2 or more years later.  In the second study, they found that the rate of change of PSA while on surveillance (up or down) predicted future treatment.  In this study, they observed that PSA was highly variable while on surveillance and statisticians at the University of Washington developed a sophisticated method to “smooth out” those fluctuations that improved prediction.  In that same study, they found that PSA testing can be safely done every 6 months, rather than more frequently, for men on surveillance.

Research Highlights: Biomarkers of Renal Obstruction

Urinary obstruction is a common cause of kidney failure and can be challenging to diagnose.  Using several models of urinary obstruction, Dr. James Brooks and colleagues identified a set of RNAs that can be measured in the urine that are candidates for predicting permanent kidney damage.  These results were recently published online in the American Journal of Physiology-renal Physiology.

Urology faculty Drs. Phil Hanno and Alan Thong attend the Stanford Health Care Warriors event with Urology NP Cate Arima at Oracle Arena.

Make a difference

Help Support Us

Please consider making a donation to Stanford Urology. In these days of markedly reduced research funding from government sources, these donations are absolutely critical to help us accomplish our research goals. Your support is invaluable and very much appreciated.

#Follow Us!